JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.68% |
| 2 | Financials | 11.13% |
| 3 | Consumer Discretionary | 9.78% |
| 4 | Healthcare | 9.62% |
| 5 | Industrials | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4876
iBio
IBIO
$70M
| $280K | ﹤0.01% |
372
-809
| -69% | -$590K |
|
|
HCICW
4877
DELISTED
Hennessy Capital Investment Corp. V Warrant
HCICW
| – | – |
0
| – | – |
|
4878
Cibus
CBUS
$122M
| $279K | ﹤0.01% |
1,391
+773
| +125% | +$184K |
|
4879
Mistras Group
MG
$578M
| $279K | ﹤0.01% |
28,401
-24,462
| -46% | -$264K |
|
|
GBL
4880
DELISTED
GAMCO Investors, Inc.
GBL
| $279K | ﹤0.01% |
11,096
-6,532
| -37% | -$149K |
|
|
VWTR
4881
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $279K | ﹤0.01% |
20,973
-29,548
| -58% | -$304K |
|
4882
Century Casinos
CNTY
$35.2M
| $277K | ﹤0.01% |
20,693
-68,947
| -77% | -$900K |
|
4883
BioXcel Therapeutics
BTAI
$36.1M
| $276K | ﹤0.01% |
593
+80
| +16% | +$43.6K |
|
4884
Minerva Neurosciences
NERV
$208M
| $275K | ﹤0.01% |
14,820
-8,326
| -36% | -$179K |
|
4885
Playtika
PLTK
$954M
| $275K | ﹤0.01% |
11,553
+853
| +8% | +$22.3K |
|
4886
BayCom
BCML
$341M
| $274K | ﹤0.01% |
15,296
-20,266
| -57% | -$368K |
|
4887
Commercial Vehicle Group
CVGI
$130M
| $274K | ﹤0.01% |
25,764
+24,854
| +2,731% | +$275K |
|
4888
iShares Emerging Markets Dividend ETF
DVYE
$1.21B
| $274K | ﹤0.01% |
7,050
+4,000
| +131% | +$160K |
|
|
EMKR
4889
DELISTED
Emcore Corp
EMKR
| $274K | ﹤0.01% |
2,979
+1,883
| +172% | +$152K |
|
|
CEMI
4890
DELISTED
Chembio diagnostics, Inc.
CEMI
| $274K | ﹤0.01% |
92,364
-2,625
| -3% | -$9.15K |
|
4891
Curis
CRIS
$4.03M
| $270K | ﹤0.01% |
+84
| New | +$380K |
|
4892
Fresenius Medical Care
FMS
$12.7B
| $270K | ﹤0.01% |
6,488
+4,326
| +200% | +$173K |
|
|
XOMA
4893
DELISTED
Xoma
XOMA
| $270K | ﹤0.01% |
7,921
-9,394
| -54% | -$315K |
|
|
PFBI
4894
DELISTED
Premier Financial Bancorp
PFBI
| $270K | ﹤0.01% |
16,044
-27,922
| -64% | -$517K |
|
4895
SAB Biotherapeutics
SABS
$341M
| $269K | ﹤0.01% |
2,692
| – | – |
|
|
SEAC
4896
DELISTED
Seachange International Inc
SEAC
| $269K | ﹤0.01% |
10,445
+5,783
| +124% | +$136K |
|
4897
CALL
Academy Sports + Outdoors
ASO
$2.98B
| $268K | ﹤0.01% |
+6,500
| New | +$228K |
|
4898
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.76B
| $268K | ﹤0.01% |
4,923
+1,173
| +31% | +$62.6K |
|
4899
Alpha Metallurgical Resources
AMR
$2.07B
| $267K | ﹤0.01% |
10,418
-41,104
| -80% | -$706K |
|
4900
Navigator Holdings
NVGS
$1.29B
| $267K | ﹤0.01% |
24,377
+3,201
| +15% | +$33.8K |
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q2 2021, opening 694 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 694 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.